Hong Kai Sha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hong Kai Sha has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Dongkai Wang
Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, People’s Republic of China
1 shared publication Jing Ji
Taizhou University, Jiangsu, China
1 shared publicationKuiyong Dong
Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, Guangdong 510006, China
1 shared publication- Lu Sun
School of Pharmacy, Taizhou University, Taizhou 225300, P. R. China
1 shared publication Shuai Wen
Taizhou University, Jiangsu, China
1 shared publication- Shuai Wen
School of Pharmacy, Taizhou University, Taizhou 225300, P. R. China
1 shared publication
Latest Publications
- 20 July 2026
- Published by Georg Thieme Verlag KG in Synthesis
- Vol. 58 (19) , 2275-2282
Copper/Brønsted Acid Cocatalyzed Mannich Reaction of Internal Alkenes with Isatin-Derived Ketimines
A cooperative copper/brønsted acid catalytic system has been developed for the Mannich reaction of internal alkenes with isatin-derived ketimines. Using α-oxo ketene dithioacetals as polarized internal alkene nucleophiles, the reaction affords 3-aminooxindole derivatives in up to 86% yield under mild conditions. The transformation exhibits broad substrate scope, tolerating various protecting groups and substituents on both reaction partners.
- 20 July 2026
- Published by Georg Thieme Verlag KG in Synthesis
- Vol. 58 (19) , 2275-2282
Copper/Brønsted Acid Cocatalyzed Mannich Reaction of Internal Alkenes with Isatin-Derived Ketimines
A cooperative copper/brønsted acid catalytic system has been developed for the Mannich reaction of internal alkenes with isatin-derived ketimines. Using α-oxo ketene dithioacetals as polarized internal alkene nucleophiles, the reaction affords 3-aminooxindole derivatives in up to 86% yield under mild conditions. The transformation exhibits broad substrate scope, tolerating various protecting groups and substituents on both reaction partners.
- 17 February 2026
- Published by World Scientific Pub Co Pte Ltd in Nano
Preparation, Characterization and in vitro Pharmacological Evaluation of PLGA-Encapsulated Tofacitinib Nanoparticulate Drug Delivery Systems for the Treatment of Rheumatoid Arthritis
Tofacitinib (Tof), a JAK3 inhibitor, is clinically utilized for the treatment of moderate to severe rheumatoid arthritis (RA). However, long-term oral administration of Tof can lead to serious systemic toxicity and adverse effects. To mitigate its toxicity, this study prepared drug-loaded nanoparticles (NPs), PLGA@Tof, utilizing poly (lactic-co-glycolic acid) PLGA as the matrix. These NPs exhibited a particle size of 220[ ]nm, a zeta potential of −13.4[ ]mV, drug loading and encapsulation efficiency were 4.12% and 40.57%, and a smooth spherical morphology. In vitro studies demonstrated that these NPs achieved sustained release of Tof without inducing hemolytic effects; less than 50% Tof was released within 24[ ]h under [ ]H 5.0 and [ ]H 7.4 conditions. Cellular experiments revealed that the uptake rates of NPs at 1[ ]h, 2[ ]h, 4[ ]h and 8[ ]h in RAW264.7 cells were significantly higher than that of the free drug under inflammatory conditions. After 8 h of treatment with PLGA@Tof on inflammatory RAW264.7 cells, the intracellular reactive oxygen species (ROS) level was significantly lower compared to the free Tof treatment group, while the levels of TNF-[ ], IL-1 [ ] and IL-6 were also significantly reduced in the PLGA@Tof treatment group. These findings suggest that PLGA@Tof has the potential to be developed into a long-acting nanotherapeutic agent for systemic or localized injection in the treatment of RA.
- 17 February 2026
- Published by World Scientific Pub Co Pte Ltd in Nano
Preparation, Characterization and in vitro Pharmacological Evaluation of PLGA-Encapsulated Tofacitinib Nanoparticulate Drug Delivery Systems for the Treatment of Rheumatoid Arthritis
Tofacitinib (Tof), a JAK3 inhibitor, is clinically utilized for the treatment of moderate to severe rheumatoid arthritis (RA). However, long-term oral administration of Tof can lead to serious systemic toxicity and adverse effects. To mitigate its toxicity, this study prepared drug-loaded nanoparticles (NPs), PLGA@Tof, utilizing poly (lactic-co-glycolic acid) PLGA as the matrix. These NPs exhibited a particle size of 220[ ]nm, a zeta potential of −13.4[ ]mV, drug loading and encapsulation efficiency were 4.12% and 40.57%, and a smooth spherical morphology. In vitro studies demonstrated that these NPs achieved sustained release of Tof without inducing hemolytic effects; less than 50% Tof was released within 24[ ]h under [ ]H 5.0 and [ ]H 7.4 conditions. Cellular experiments revealed that the uptake rates of NPs at 1[ ]h, 2[ ]h, 4[ ]h and 8[ ]h in RAW264.7 cells were significantly higher than that of the free drug under inflammatory conditions. After 8 h of treatment with PLGA@Tof on inflammatory RAW264.7 cells, the intracellular reactive oxygen species (ROS) level was significantly lower compared to the free Tof treatment group, while the levels of TNF-[ ], IL-1 [ ] and IL-6 were also significantly reduced in the PLGA@Tof treatment group. These findings suggest that PLGA@Tof has the potential to be developed into a long-acting nanotherapeutic agent for systemic or localized injection in the treatment of RA.
- 11 October 2022
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 20 (42) , 8223-8227
A copper-catalyzed three-component reaction of dithioacetals with diazo ketones and ketimines
An efficient protocol for the synthesis of various acyclic thioacetal derivatives and medium-size sulfur-containing heterocycles via copper-catalyzed three-component reaction of dithioacetals with diazo-ketones and ketimines was reported.
- 11 October 2022
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 20 (42) , 8223-8227
A copper-catalyzed three-component reaction of dithioacetals with diazo ketones and ketimines
An efficient protocol for the synthesis of various acyclic thioacetal derivatives and medium-size sulfur-containing heterocycles via copper-catalyzed three-component reaction of dithioacetals with diazo-ketones and ketimines was reported.